Literature DB >> 30219257

Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Gabor Kovacs1, Daniel Dumitrescu2, Andreas Barner3, Sebastian Greiner4, Ekkehard Grünig5, Alfred Hager6, Thomas Köhler7, Rainer Kozlik-Feldmann8, Irmtraut Kruck9, Astrid E Lammers10, Derliz Mereles4, Andreas Meyer11, Joachim Meyer12, Stefan Pabst13, Hans-Jürgen Seyfarth14, Christoph Sinning15, Stephan Sorichter16, Gerd Stähler17, Heinrike Wilkens18, Matthias Held19.   

Abstract

In the summer of 2016, delegates from the German Society of Cardiology (DGK), the German Respiratory Society (DGP), and the German Society of Pediatric Cardiology (DGPK) met in Cologne, Germany, to define consensus-based practice recommendations for the management of patients with pulmonary hypertension (PH). These recommendations were built on the 2015 European Pulmonary Hypertension guidelines, aiming at their practical implementation, considering country-specific issues, and including new evidence, where available. To this end, a number of working groups was initiated, one of which was specifically dedicated to the definition, clinical classification and initial diagnosis of PH. While the European guidelines provide a detailed clinical classification and a structured approach for diagnostic testing, their application in routine care may be challenging, particularly given the changing phenotype of PH patients who are nowadays often elderly and may present with multiple potential causes of PH, as well as comorbid conditions. Specifically, the working group addresses the thoroughness of diagnostic testing, and the roles of echocardiography, exercise testing, and genetic testing in diagnosing PH. Furthermore, challenges in the diagnostic work-up of patients with various causes of PH including "PAH with comorbidities", CTEPH and coexisting conditions are highlighted, and a modified diagnostic algorithm is provided. The detailed results and recommendations of the working group on definition, clinical classification and initial diagnosis of PH, which were last updated in the spring of 2018, are summarized in this article.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Classification; Definition; Diagnosis; Pulmonary hypertension

Mesh:

Year:  2018        PMID: 30219257     DOI: 10.1016/j.ijcard.2018.08.083

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  26 in total

1.  Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  David J R Fulton; Xueyi Li; Zsuzsanna Bordan; Yusi Wang; Keyvan Mahboubi; R Daniel Rudic; Stephen Haigh; Feng Chen; Scott A Barman
Journal:  Antioxid Redox Signal       Date:  2019-03-29       Impact factor: 8.401

Review 2.  Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra.

Authors:  Keshava Rajagopal; Andrew J Bryant; Sandeep Sahay; Nancy Wareing; Yang Zhou; Lavannya M Pandit; Harry Karmouty-Quintana
Journal:  Br J Pharmacol       Date:  2020-04-07       Impact factor: 8.739

3.  Chronic thromboembolic pulmonary hypertension: anticoagulation and beyond.

Authors:  Karlyn A Martin; Michael J Cuttica
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Muscle training in patients with pulmonary hypertension. a narrative review.

Authors:  Vicente Benavides-Cordoba; Martijn A Spruit
Journal:  Colomb Med (Cali)       Date:  2021-12-30

Review 5.  Cardiac natriuretic peptides.

Authors:  Jens P Goetze; Benoit G Bruneau; Hugo R Ramos; Tsuneo Ogawa; Mercedes Kuroski de Bold; Adolfo J de Bold
Journal:  Nat Rev Cardiol       Date:  2020-05-22       Impact factor: 32.419

Review 6.  Right Heart Catheterization-Background, Physiological Basics, and Clinical Implications.

Authors:  Grzegorz M Kubiak; Agnieszka Ciarka; Monika Biniecka; Piotr Ceranowicz
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

7.  A cross-sectional study of acute cor pulmonale in acute respiratory distress syndrome patients in China.

Authors:  Long-Xiang Su; Xiu-Ling Shang; Ran Zhu; Wei He; Pan Pan; Hong-Min Zhang; Li-Na Zhang; Da-Wei Liu; Rong-Guo Yu; Xiao-Ting Wang
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

8.  The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.

Authors:  Mehreen Batool; Eva M Berghausen; Mario Zierden; Marius Vantler; Ralph T Schermuly; Stephan Baldus; Stephan Rosenkranz; Henrik Ten Freyhaus
Journal:  Basic Res Cardiol       Date:  2020-11-13       Impact factor: 17.165

9.  Efficacy and safety of statin therapy in pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Fangying Chen; Mei Yang; Chun Wan; Lin Liu; Lei Chen
Journal:  Ann Transl Med       Date:  2019-12

10.  Pulmonary tumour thrombotic microangiopathy presented as gastric signet ring cell carcinoma: A case report.

Authors:  Ning Cui; Lijun Wang; Jingming Zhao
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.